PL2144625T3 - Kompozycja enzymatyczna o kontrolowanym uwalnianiu i sposoby zastosowania - Google Patents

Kompozycja enzymatyczna o kontrolowanym uwalnianiu i sposoby zastosowania

Info

Publication number
PL2144625T3
PL2144625T3 PL07865205T PL07865205T PL2144625T3 PL 2144625 T3 PL2144625 T3 PL 2144625T3 PL 07865205 T PL07865205 T PL 07865205T PL 07865205 T PL07865205 T PL 07865205T PL 2144625 T3 PL2144625 T3 PL 2144625T3
Authority
PL
Poland
Prior art keywords
methods
controlled release
enzymatic composition
release enzymatic
composition
Prior art date
Application number
PL07865205T
Other languages
English (en)
Inventor
Terence M. Dolak
Max Rutman
Jan Vincent
Kristian Hellgren
Original Assignee
Marizyme, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marizyme, Inc. filed Critical Marizyme, Inc.
Publication of PL2144625T3 publication Critical patent/PL2144625T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07865205T 2006-12-05 2007-12-05 Kompozycja enzymatyczna o kontrolowanym uwalnianiu i sposoby zastosowania PL2144625T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86865606P 2006-12-05 2006-12-05
PCT/US2007/086455 WO2008070698A1 (en) 2006-12-05 2007-12-05 A controlled release enzymatic composition and methods of use
EP07865205.4A EP2144625B1 (en) 2006-12-05 2007-12-05 A controlled release enzymatic composition and methods of use

Publications (1)

Publication Number Publication Date
PL2144625T3 true PL2144625T3 (pl) 2022-05-23

Family

ID=39492617

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07865205T PL2144625T3 (pl) 2006-12-05 2007-12-05 Kompozycja enzymatyczna o kontrolowanym uwalnianiu i sposoby zastosowania

Country Status (6)

Country Link
US (1) US20110135625A1 (pl)
EP (2) EP2144625B1 (pl)
DK (1) DK2144625T3 (pl)
ES (1) ES2912987T3 (pl)
PL (1) PL2144625T3 (pl)
WO (1) WO2008070698A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015520124A (ja) * 2012-04-05 2015-07-16 アルチンボルド エービーＡｒｃｉｍｂｏｌｄｏ Ａｂ バイオフィルムの除去における使用のためのナンキョクオキアミからの酵素の混合物

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296094A (en) * 1966-05-05 1967-01-03 Baxter Laboratories Inc Stabilized aqueous enzyme solutions
NL6812443A (pl) 1968-08-31 1970-03-03
US3627688A (en) * 1968-11-12 1971-12-14 Procter & Gamble Stabilized aqueous enzyme containing compositions
CA941765A (en) 1969-05-02 1974-02-12 The Procter And Gamble Company Enzyme-containing detergent compositions for neutral washing
DE2130833A1 (de) 1971-06-22 1973-01-11 Brinkmann Kg Wilhelm Verfahren zum reinigen von medizinischen geraeten
US3855142A (en) * 1971-07-15 1974-12-17 Lever Brothers Ltd Enzymatic denture cleanser
US4307081A (en) * 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
DE2458118C2 (de) 1974-12-09 1976-12-30 Siemens AG, 1000 Berlin und 8000 München Verfahren und Anordnung zur Faksimilecodierung
GB1573964A (en) 1976-04-20 1980-08-28 Klein G K V Enzyme material
JPS536483A (en) * 1976-07-02 1978-01-20 Tanabe Seiyaku Co Ltd Composition having enzymatic activity and its preparation
CA1093991A (en) * 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
GB1603640A (en) 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
US4212761A (en) 1978-03-06 1980-07-15 Novo Laboratories, Inc. Method and composition for cleaning dairy equipment
US4243546A (en) 1979-03-23 1981-01-06 The Drackett Company Stable aqueous compositions containing enzymes
US4287082A (en) 1980-02-22 1981-09-01 The Procter & Gamble Company Homogeneous enzyme-containing liquid detergent compositions containing saturated acids
JPS57115179A (en) * 1981-01-09 1982-07-17 Tanabe Seiyaku Co Ltd Immobilized enzymatic active substance and its preparation
DE3379589D1 (en) * 1982-10-25 1989-05-18 Hellgren Lars G I Enzyme composition for cleaning, the use thereof and preparation of the composition
SE8302268L (sv) * 1983-04-22 1984-10-23 Lars G I Hellgren Ny kombination av proteolytiska och lipolytiska enzymer lemplig som tvettkomposition
DE3581320D1 (de) * 1984-06-26 1991-02-21 Hoechst Ag Verfahren zur herstellung von wasserloeslichen polysacchariden, die so erhaeltlichen saccharide und ihre verwendung.
JP2568885B2 (ja) * 1988-05-09 1997-01-08 忠生 白石 酵素配合トイレタリー製品
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
US5133968A (en) * 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US7947270B2 (en) 1992-05-22 2011-05-24 Arcimboldo Ab Removing dental plaque with krill enzymes
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
US5958406A (en) 1994-11-22 1999-09-28 Phairson Medical Inc. Acne treatment with multifunctional enzyme
US20060134641A1 (en) 1992-05-22 2006-06-22 Franklin Richard L Treating viral infections with krill enzymes
US5356800A (en) * 1992-11-30 1994-10-18 Buckman Laboratories International, Inc. Stabilized liquid enzymatic compositions
FR2704752B1 (fr) * 1993-05-03 1995-07-21 Oreal Composition cosmétique sous forme de gel aqueux.
FR2737116B1 (fr) * 1995-07-25 1997-08-22 Oreal Composition stable contenant un actif cosmetique et/ou dermatologique sensible a l'eau
FR2737115B1 (fr) * 1995-07-25 1997-08-22 Oreal Composition stable contenant une enzyme
FR2737122B1 (fr) * 1995-07-25 1997-09-12 Oreal Composition stable contenant de l'acide ascorbique
US5811112A (en) * 1997-05-30 1998-09-22 Chesebrough-Pond's Usa Co., Division Of Conopco Inc. Oil-in-water cosmetic emulsions containing a stabilized protease
US6524814B1 (en) 1997-08-28 2003-02-25 Phairson Medical, Inc. Enzyme and DNA sequence encoding krill-derived multifunctional protein
KR20020000143A (ko) 1999-02-23 2002-01-04 페어슨 메디칼 인크. 외상의 치료
WO2001082945A2 (en) * 2000-04-28 2001-11-08 New Horizons Diagnostic Corporation The use of bacterial phage associated lysing enzymes for treating various illnesses
US20030206897A1 (en) * 2000-09-13 2003-11-06 The Procter & Gamble Company Cosmetic compositions
WO2003000625A2 (en) * 2001-06-22 2003-01-03 Genencor International, Inc. Highly impact-resistant granules
US20040247654A1 (en) * 2003-06-05 2004-12-09 3M Innovative Properties Company Hydrophilic adhesives for delivery of herbal medicines
AR059012A1 (es) * 2006-01-13 2008-03-05 Aker Biomarine Asa Extractos derivados del krill

Also Published As

Publication number Publication date
EP2144625B1 (en) 2022-02-09
DK2144625T3 (da) 2022-05-09
EP4005589B1 (en) 2024-04-10
WO2008070698A1 (en) 2008-06-12
EP4005589A1 (en) 2022-06-01
EP2144625A4 (en) 2012-11-21
EP2144625A1 (en) 2010-01-20
US20110135625A1 (en) 2011-06-09
ES2912987T3 (es) 2022-05-30

Similar Documents

Publication Publication Date Title
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2043647A4 (en) FORMULATION WITH TAXED RELEASE AND CORRESPONDING METHODS
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP2132987A4 (en) NEMATIC COMPOSITION AND METHOD OF USE THEREOF
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP2134351A4 (en) METHODS AND COMPOSITIONS USED FOR PROLONGED CHROMIUM RELEASE
EP2046129A4 (en) HERBICIDE COMPOSITION AND METHOD OF USE
IL202424A0 (en) Telomerase activating compounds and methods of use thereof
IL206125A0 (en) Azaindolizines and methods of use
PT2046128E (pt) Composição herbicida e seu método de utilização
EP2046116A4 (en) HERBICIDE COMPOSITION AND METHOD OF USE
IL192564A0 (en) Composition and method of use thereof
PT2046118E (pt) Composição herbicida e método de utilização da mesma
ZA201004894B (en) Nuctraceutical composition and methods of use
EP2101575A4 (en) ACE2 ACTIVATOR COMPOUNDS AND METHOD OF USE THEREOF
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
EP2144625A4 (en) ENZYMATIC COMPOSITION WITH CONTROLLED RELEASE AND APPLICATION METHOD
EP2043428A4 (en) MODULATORS OF RNF5 AND USES THEREOF
ZA201004893B (en) Nuctraceutical composition and methods of use
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
AU2006907075A0 (en) Compounds and Methods of Use